Edition:
United Kingdom

Linical Co Ltd (2183.T)

2183.T on Tokyo Stock Exchange

1,419JPY
17 Nov 2017
Change (% chg)

¥21 (+1.50%)
Prev Close
¥1,398
Open
¥1,405
Day's High
¥1,431
Day's Low
¥1,405
Volume
96,700
Avg. Vol
104,302
52-wk High
¥1,973
52-wk Low
¥1,195

Summary

Name Age Since Current Position

Kazuhiro Hatano

49 2010 President, Chief Director of Development, Representative Director

Akihiro Takahashi

47 2009 Senior Managing Director, Chief Financial Officer, Chief Director of Administration

Keigo Tsujimoto

50 2011 Vice President, Manager of International Business Development Office, President of Subsidiary, Director

Jun Kawai

44 2013 Senior Managing Director, Deputy Chief Director of Development (Osaka), Director of 3rd Development, Chairman & President of Subsidiaries

Yoshio Kaji

56 2009 Managing Director, Manager of Business Planning Office

Masaya Miyazaki

41 2013 Managing Director, Deputy Chief Director of Development (Tokyo), Director of 2nd Development

Isao Sakamoto

38 2011 Director of 1st Development Contract Business of Oncology in Business Planning Office, Director

Shiori Yamaguchi

37 2009 Manager of Audit Office, Director

Kazuhiro Tajiri

55 2012 Director

Masafumi Nogimori

69 2017 Independent Director

Biographies

Name Description

Kazuhiro Hatano

Mr. Kazuhiro Hatano has been serving as President, Chief Director of Development and Representative Director in Linical Co., Ltd. since February 2010. He used to work for a company under the new name of Astellas Pharma Inc., Maruho Co., Ltd., Aurora Co., Ltd. and another company.

Akihiro Takahashi

Mr. Akihiro Takahashi has been serving as Senior Managing Director, Chief Financial Officer and Chief Director of Administration in Linical Co., Ltd. since April 2009. He established the Company in April 2007, and served as Managing Director. He used to work for Toyama Chemical Company, Limited, Astellas Pharma Inc. and Aurora Co., Ltd. and three other companies. He obtained his Master's Degree in Medical Technology from University of Tsukuba in March 1995.

Keigo Tsujimoto

Mr. Keigo Tsujimoto has been serving as Vice President, Manager of International Business Development Office and Director in Linical Co., Ltd., as well as President and Representative Director in a subsidiary, Lincal USA., Inc., since July 2011. He used to work for a company under the new name of Dainippon Sumitomo Pharma Co., Ltd., SHIN NIPPON BIOMEDICAL LABORATORIES, LTD., EPS Co., Ltd, Senju Pharmaceutical Co., Ltd., Ferring Pharmaceutical Co., Ltd., and other two companies.

Jun Kawai

Mr. Jun Kawai has been serving as Senior Managing Director, Deputy Chief Director of Development (Osaka) and Director of 3rd Development in Linical Co., Ltd., as well as Chairman of the Board of a subsidiary, LINICAL TAIWAN CO., LTD., and President and Representative Director of another subsidiary, LINICAL KOREA CO., LTD., since June 2013. He used to work for a company that is under the new name of Bayer HealthCare, and another company that is under the new name of Glaxo SmithKline K.K., Shionogi & Co., Ltd., Aurora Co., Ltd., as well as another company.

Yoshio Kaji

Mr. Yoshio Kaji has been serving as Managing Director and Manager of Business Planning Office in Linical Co., Ltd. since June 2009. He is also serving as Director in a subsidiary, LINICAL USA., INC. He joined the Company in October 2007. He previously served as Managing Executive Officer in the Company. He used to work for a company that is under the new name Astellas Pharma Inc.

Masaya Miyazaki

Mr. Masaya Miyazaki has been serving as Managing Director, Deputy Chief Director of Development (Tokyo) and Director of 2nd Development in Linical Co., Ltd. since June 2013. He used to work for a company under the new name of Astellas Pharma Inc., Ferring Pharmaceuticals Co., Ltd. and another company.

Isao Sakamoto

Mr. Isao Sakamoto has been serving as Director of 1st Development Contract Business of Oncology in Business Planning Office and Director in Linical Co., Ltd. since April 2011. He joined the Company in July 2005, and served as Director of 4th Development. He is also serving as Director in three subsidiaries, LINICAL USA, INC., LINICAL TAIWAN CO., LTD. and LINICAL KOREA CO., LTD. He used to work for a company that is under the new name of Astella Pharma Inc. and Aurora Co., Ltd.

Shiori Yamaguchi

Mr. Shiori Yamaguchi has been serving as Manager of Audit Office and Director in Linical Co., Ltd. since June 2009. He joined the Company in June 2007. He used to work for a company that is under the new name Astella Pharma Inc., Aurora Co., Ltd., as well as two other companies.

Kazuhiro Tajiri

Mr. Kazuhiro Tajiri has been serving as Director in Linical Co., Ltd. since July 2012. He joined the Company in October 2010. He used to work for Astellas Pharma Inc. and its former entity.

Masafumi Nogimori

Mr. Masafumi Nogimori was named Independent Director in Linical Co., Ltd. effective July 1, 2017. He used to work for Fujisawa Pharmaceutical Co., Ltd.